Oramed Pharmaceuticals Inc.

Historical 13F Holders

Symbol
ORMP
CUSIP
68403P203
All holders as of
Q2 2025
Type
Equity
Class
COM NEW
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q3 6 48.1 k $124 k
2025 Q2 50 7.25 M $16.3 M
2025 Q1 55 7.77 M $16.6 M
2024 Q4 59 7.67 M $18.6 M
2024 Q3 57 6.96 M $17.0 M
2024 Q2 61 5.99 M $15.4 M
2024 Q1 56 5.36 M $15.7 M
2023 Q4 61 5.25 M $12.1 M
2023 Q3 58 2.30 M $5.99 M
2023 Q2 54 2.28 M $8.16 M
2023 Q1 65 4.26 M $9.30 M
2022 Q4 86 3.65 M $43.8 M
2022 Q3 77 3.94 M $25.5 M
2022 Q2 94 6.69 M $31.0 M
2022 Q1 115 9.07 M $78.5 M
2021 Q4 133 8.75 M $125 M
2021 Q3 103 5.41 M $119 M
2021 Q2 83 3.84 M $51.4 M
2021 Q1 52 1.30 M $64.8 M
2020 Q4 45 1.46 M $6.19 M
2020 Q3 37 2.00 M $5.19 M
2020 Q2 38 1.35 M $4.73 M
2020 Q1 35 639 k $1.97 M
2019 Q4 36 641 k $3.30 M
2019 Q3 31 760 k $2.43 M
2019 Q2 27 839 k $3.01 M
2019 Q1 26 1.07 M $3.91 M
2018 Q4 31 1.90 M $5.76 M
2018 Q3 30 1.76 M $8.56 M
2018 Q2 22 281 k $2.09 M
2018 Q1 22 301 k $2.01 M
2017 Q4 27 378 k $3.40 M
2017 Q3 23 276 k $2.73 M
2017 Q2 25 180 k $1.35 M
2017 Q1 24 162 k $995 k
2016 Q4 26 156 k $952 k
2016 Q3 24 182 k $1.32 M
2016 Q2 29 291 k $2.43 M
2016 Q1 29 201 k $1.32 M
2015 Q4 30 210 k $1.78 M
2015 Q3 20 157 k $855 k
2015 Q2 18 335 k $1.91 M
2015 Q1 18 544 k $3.37 M
2014 Q4 24 1.00 M $5.61 M
2014 Q3 20 1.38 M $11.1 M
2014 Q2 25 1.43 M $13.7 M
2014 Q1 24 1.31 M $15.3 M